CRISPR Therapeutics (CRSP)
(Delayed Data from NSDQ)
$70.16 USD
-0.81 (-1.14%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $70.13 -0.03 (-0.04%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -1.63 |
EPS Last Quarter | 1.10 |
Last EPS Surprise | 375.00% |
ABR | 2.17 |
Earnings ESP
|
-4.38% |
---|---|
Current Year | -6.24 |
Next Year | -4.39 |
EPS (TTM) | -1.96 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.31M | 10.62M | 105.41M | 567.23M |
# of Estimates | 5 | 9 | 11 | 10 |
High Estimate | 19.50M | 30.30M | 457.90M | 3.31B |
Low Estimate | 0.38M | 0.38M | 22.00M | 69.00M |
Year ago Sales | 100.00M | 70.00M | 371.21M | 105.41M |
Year over Year Growth Est. | -91.69% | -84.83% | -71.60% | 438.12% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.63 | -1.67 | -6.24 | -4.39 |
# of Estimates | 11 | 10 | 14 | 13 |
Most Recent Consensus | -1.71 | -1.68 | -6.37 | -4.87 |
High Estimate | -1.19 | -1.13 | -4.22 | 5.08 |
Low Estimate | -2.07 | -2.29 | -8.63 | -7.33 |
Year ago EPS | -0.67 | -0.98 | -1.94 | -6.24 |
Year over Year Growth Est. | -143.28% | -70.41% | -221.65% | 29.58% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 1 |
Up Last 60 Days | 4 | 5 | 7 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 3 | 2 |
Down Last 60 Days | 4 | 3 | 7 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.63 | -1.67 | -6.24 | -4.39 |
7 Days Ago | -1.63 | -1.67 | -6.24 | -4.39 |
30 Days Ago | -1.44 | -1.65 | -6.06 | -4.05 |
60 Days Ago | -1.78 | -1.82 | -5.79 | -1.81 |
90 Days Ago | -1.80 | -1.85 | -5.37 | -1.98 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.70 | -1.81 | -6.28 | -4.98 |
Zacks Consensus Estimate | -1.63 | -1.67 | -6.24 | -4.39 |
Earnings ESP | -4.38% | -8.51% | -0.67% | -13.51% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.10 | -1.41 | -0.98 | -0.67 | NA |
Estimate | -0.40 | -1.98 | -2.18 | -1.67 | NA |
Difference | 1.50 | 0.57 | 1.20 | 1.00 | 1.07 |
Surprise | 375.00% | 28.79% | 55.05% | 59.88% | 129.68% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more